Harvard Bioscience Inc
NASDAQ:HBIO

Watchlist Manager
Harvard Bioscience Inc Logo
Harvard Bioscience Inc
NASDAQ:HBIO
Watchlist
Price: 0.6304 USD -3.3% Market Closed
Market Cap: 28.1m USD

Wall Street
Price Targets

HBIO Price Targets Summary
Harvard Bioscience Inc

Wall Street analysts forecast HBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HBIO is 2.04 USD with a low forecast of 2.02 USD and a high forecast of 2.1 USD.

Lowest
Price Target
2.02 USD
220% Upside
Average
Price Target
2.04 USD
224% Upside
Highest
Price Target
2.1 USD
233% Upside
Harvard Bioscience Inc Competitors:
Price Targets
MCAP
MedCap AB (publ)
16% Upside
688315
Novogene Co Ltd
7% Upside
CGEN
Compugen Ltd
239% Upside
IQV
IQVIA Holdings Inc
7% Upside
TKNO
Alpha Teknova Inc
119% Upside
LONN
Lonza Group AG
23% Upside
A
Agilent Technologies Inc
15% Upside
TMO
Thermo Fisher Scientific Inc
4% Upside

Revenue
Forecast

Revenue Estimate
Harvard Bioscience Inc

For the last 13 years the compound annual growth rate for Harvard Bioscience Inc's revenue is -1%. The projected CAGR for the next 2 years is 0%.

-1%
Past Growth
0%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Harvard Bioscience Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-67%
Average Miss

Net Income
Forecast

Net Income Estimate
Harvard Bioscience Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HBIO's stock price target?
Price Target
2.04 USD

According to Wall Street analysts, the average 1-year price target for HBIO is 2.04 USD with a low forecast of 2.02 USD and a high forecast of 2.1 USD.

What is Harvard Bioscience Inc's Revenue forecast?
Projected CAGR
0%

For the last 13 years the compound annual growth rate for Harvard Bioscience Inc's revenue is -1%. The projected CAGR for the next 2 years is 0%.

Back to Top